Citadel Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$668M Buy
5,551,800
+2,173,900
+64% +$251M 0.11% 131
2025
Q4
$356M Sell
3,377,900
-2,539,600
-43% -$238M 0.05% 279
2025
Q3
$497M Buy
5,917,500
+60,000
+1% +$4.94M 0.08% 188
2025
Q2
$464M Buy
5,857,500
+440,100
+8% +$35M 0.08% 175
2025
Q1
$486M Buy
5,417,400
+1,544,800
+40% +$144M 0.09% 133
2024
Q4
$385M Buy
3,872,600
+1,178,300
+44% +$121M 0.07% 204
2024
Q3
$306M Buy
2,694,300
+256,200
+11% +$30.4M 0.06% 241
2024
Q2
$302M Sell
2,438,100
-397,900
-14% -$51.3M 0.06% 236
2024
Q1
$374M Buy
2,836,000
+105,300
+4% +$13M 0.07% 187
2023
Q4
$298M Sell
2,730,700
-37,100
-1% -$3.85M 0.06% 216
2023
Q3
$285M Buy
2,767,800
+519,600
+23% +$56M 0.06% 207
2023
Q2
$259M Sell
2,248,200
-246,800
-10% -$28M 0.05% 233
2023
Q1
$265M Sell
2,495,000
-1,092,900
-30% -$118M 0.06% 223
2022
Q4
$398M Sell
3,587,900
-193,000
-5% -$19.7M 0.09% 151
2022
Q3
$326M Buy
3,780,900
+811,400
+27% +$72.4M 0.07% 174
2022
Q2
$271M Sell
2,969,500
-656,900
-18% -$58.2M 0.07% 195
2022
Q1
$298M Sell
3,626,400
-643,400
-15% -$50.7M 0.06% 216
2021
Q4
$327M Buy
4,269,800
+123,800
+3% +$9.86M 0.07% 187
2021
Q3
$311M Buy
4,146,000
+633,900
+18% +$48.2M 0.06% 206
2021
Q2
$273M Buy
3,512,100
+1,160,178
+49% +$86.3M 0.06% 225
2021
Q1
$173M Sell
2,351,922
-420,667
-15% -$31M 0.04% 340
2020
Q4
$216M Buy
2,772,589
+997,591
+56% +$76.3M 0.06% 237
2020
Q3
$140M Buy
1,774,998
+149,969
+9% +$11.7M 0.04% 304
2020
Q2
$120M Sell
1,625,029
-318,277
-16% -$24M 0.04% 339
2020
Q1
$143M Buy
1,943,306
+668,624
+52% +$52.5M 0.06% 220
2019
Q4
$111M Buy
1,274,682
+494,970
+63% +$40.7M 0.05% 348
2019
Q3
$62.6M Sell
779,712
-779,817
-50% -$62.5M 0.03% 627
2019
Q2
$125M Buy
1,559,529
+247,747
+19% +$19M 0.06% 305
2019
Q1
$104M Sell
1,311,782
-1,058,165
-45% -$79.1M 0.05% 347
2018
Q4
$173M Buy
2,369,947
+765,249
+48% +$54M 0.09% 153
2018
Q3
$109M Sell
1,604,698
-101,446
-6% -$6.46M 0.05% 383
2018
Q2
$98.8M Buy
1,706,144
+503,459
+42% +$28.4M 0.05% 373
2018
Q1
$62.5M Buy
1,202,685
+679,838
+130% +$36.7M 0.03% 498
2017
Q4
$28.1M Buy
522,847
+72,941
+16% +$4.04M 0.02% 961
2017
Q3
$27.5M Sell
449,906
-536,891
-54% -$32.6M 0.02% 883
2017
Q2
$60.3M Sell
986,797
-137,707
-12% -$8.38M 0.05% 407
2017
Q1
$68.2M Buy
1,124,504
+519,703
+86% +$31.5M 0.06% 315
2016
Q4
$34M Buy
604,801
+27,877
+5% +$1.63M 0.03% 557
2016
Q3
$34.4M Sell
576,924
-22,532
-4% -$1.32M 0.03% 572
2016
Q2
$33M Sell
599,456
-15,091
-2% -$803K 0.04% 515
2016
Q1
$31M Buy
614,547
+95,473
+18% +$4.68M 0.04% 501
2015
Q4
$26.2M Sell
519,074
-231,923
-31% -$11.7M 0.03% 694
2015
Q3
$35.4M Buy
750,997
+347,203
+86% +$18.4M 0.03% 584
2015
Q2
$21.9M Buy
403,794
+27,667
+7% +$1.55M 0.02% 935
2015
Q1
$20.6M Buy
376,127
+113,289
+43% +$6.41M 0.02% 963
2014
Q4
$14.2M Sell
262,838
-43,073
-14% -$2.4M 0.01% 1154
2014
Q3
$17.3M Buy
305,911
+90,547
+42% +$5.08M 0.02% 988
2014
Q2
$11.9M Sell
215,364
-113,498
-35% -$6.19M 0.01% 1137
2014
Q1
$17.8M Sell
328,862
-260,533
-44% -$13.5M 0.02% 888
2013
Q4
$28.1M Buy
589,395
+102,494
+21% +$4.69M 0.04% 625
2013
Q3
$22.1M Sell
486,901
-151,436
-24% -$6.91M 0.03% 674
2013
Q2
$28.3M Buy
+638,337
New +$28.5M 0.05% 468

Other funds holding MRK

Citadel Advisors's MRK Position: Q1 2026 in Review

Citadel Advisors reduced its Merck (MRK) stake by 44% in Q1 2026, selling an estimated $346M and leaving 3,821,227 shares worth $460M. The position accounts for 0.07% of the portfolio, ranked #197.

Citadel Advisors first reported a position in MRK in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.02B in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Citadel Advisors held 3,821,227 shares of Merck worth $460M as of Q1 2026.
  • Citadel Advisors sold 3,000,104 Merck shares in Q1 2026, an estimated $346M.
  • Merck made up 0.07% of Citadel Advisors's portfolio in Q1 2026, its #197 holding.
  • Citadel Advisors first reported a position in Merck in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Merck position peaked at $1.02B in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.